3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;1-methyl-3-phenyl-5-(4-phenylphenyl)pyrazole;3-phenyl-5-(4-phenylphenyl)-1,2-oxazole;3-phenyl-5-(4-phenylphenyl)-1,2-thiazole;platinum;tris(platinum(2+))
C86H63N6OPt4S+ — CID 159300782
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;1-methyl-3-phenyl-5-(4-phenylphenyl)pyrazole;3-phenyl-5-(4-phenylphenyl)-1,2-oxazole;3-phenyl-5-(4-phenylphenyl)-1,2-thiazole;platinum;tris(platinum(2+))
3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;1-methyl-3-phenyl-5-(4-phenylphenyl)pyrazole;3-phenyl-5-(4-phenylphenyl)-1,2-oxazole;3-phenyl-5-(4-phenylphenyl)-1,2-thiazole;platinum;tris(platinum(2+)) (PubChem CID 159300782) has the molecular formula C86H63N6OPt4S+ and a molecular weight of 2008.87 g/mol. Its IUPAC name is 3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;1-methyl-3-phenyl-5-(4-phenylphenyl)pyrazole;3-phenyl-5-(4-phenylphenyl)-1,2-oxazole;3-phenyl-5-(4-phenylphenyl)-1,2-thiazole;platinum;tris(platinum(2+)).
Molecular Properties
| Compound Name | 3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;1-methyl-3-phenyl-5-(4-phenylphenyl)pyrazole;3-phenyl-5-(4-phenylphenyl)-1,2-oxazole;3-phenyl-5-(4-phenylphenyl)-1,2-thiazole;platinum;tris(platinum(2+)) |
|---|---|
| PubChem CID | 159300782 |
| Molecular Formula | C86H63N6OPt4S+ |
| Molecular Weight | 2008.87 g/mol |
| Exact Mass | 2007.34 |
| IUPAC Name | 3-methyl-1-phenyl-4-(4-phenylphenyl)-2H-imidazol-2-ide;1-methyl-3-phenyl-5-(4-phenylphenyl)pyrazole;3-phenyl-5-(4-phenylphenyl)-1,2-oxazole;3-phenyl-5-(4-phenylphenyl)-1,2-thiazole;platinum;tris(platinum(2+)) |
| SMILES | CN1[CH-]N(c2[c-]cccc2)C=C1c1ccc(-c2ccccc2)cc1.Cn1nc(-c2[c-]cccc2)cc1-c1ccc(-c2ccccc2)cc1.[Pt+2].[Pt+2].[Pt+2].[Pt].[c-]1ccccc1-c1cc(-c2ccc(-c3ccccc3)cc2)on1.[c-]1ccccc1-c1cc(-c2ccc(-c3ccccc3)cc2)sn1 |
| InChI | InChI=1S/C22H18N2.C22H17N2.C21H14NO.C21H14NS.4Pt/c1-23-17-24(21-10-6-3-7-11-21)16-22(23)20-14-12-19(13-15-20)18-8-4-2-5-9-18;1-24-22(16-21(23-24)19-10-6-3-7-11-19)20-14-12-18(13-15-20)17-8-4-2-5-9-17;2*1-3-7-16(8-4-1)17-11-13-19(14-12-17)21-15-20(22-23-21)18-9-5-2-6-10-18;;;;/h2-10,12-17H,1H3;2-10,12-16H,1H3;2*1-9,11-15H;;;;/q-2;3*-1;;3*+2 |
| InChIKey | SRWXODZHZGTAGQ-UHFFFAOYSA-N |
| XLogP | 21.65 |
| TPSA | 63.22 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 98 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2008.87 |
| LogP ≤ 5 | 21.65 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159300782 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.